For Unifarco, revenues increased to EUR 93 million (+12.1%) in the first half year
2' min read
2' min read
Unifarco - a company from Belluno that researches, develops, manufactures and distributes cosmetics, nutraceuticals, dermatological products, medical devices, make-up and functional foods to pharmacies - continues to record strong growth in the first half of 2024, achieving a consolidated turnover of EUR 93 million (+12.1%) and a net profit of EUR 5.7 million.
Based in Santa Giustina (Belluno), the company operates in Italy and Europe, with 778 employees, through direct branches in Germany, Spain and France and sales networks in Austria, Belgium and Switzerland, serving over 6,300 customer pharmacies.
Geographically, turnover increased in all countries: Italy (+7.9), Spain (+26.6%), Germany (+17.2%), France and Belgium (+14.4%), Austria (+15.9%). The positive trend in turnover in Italy was also confirmed (+7.9%), allowing the group to rank second in the cumulative sales of cosmetics, make-up and food supplements with a growth in value of 5.6% (source: New Line), almost two percentage points higher than the growth in the reference market (3.7%).
The group's individual brands also showed steadily improving results. Farmacisti Preparatori (cosmetics, supplements and pharmacist's signature solutions) grew by 5.9%; Ceramol (medical devices and dermatological cosmetics with high technological content and high tolerability) +21.2%; Dolomia (phytocosmetic brand that uses the powerful extracts of Dolomitic nature to combat stress, pollution and skin ageing) +16.2%.
The performance of Biomalife, a line of dietary supplements specifically for the wellbeing of the gastrointestinal system, which almost doubled its turnover in the first half of the year, confirming the great potential of the brand as it develops, stands out. Also noteworthy are the results of Keylife, which recorded a 13.5% growth in the functional food sector, and MyCli, a range of cosmeceuticals and nutritional supplements inspired by aesthetic medicine, which recorded a double-digit increase.
